Title 21

PART 201 SUBPART D

Subpart D - Exemptions From Adequate Directions for Use

• 21 U.S.C. 321, 331, 351, 352, 353, 355, 358, 360, 360b, 360gg-360ss, 371, 374, 379e; 42 U.S.C. 216, 241, 262, 264.
• 40 FR 13998, Mar. 27, 1975, unless otherwise noted.

21:4.0.1.1.2.4.1.1	SECTION 201.100	201.100 Prescription drugs for human use.
21:4.0.1.1.2.4.1.2	SECTION 201.105	201.105 Veterinary drugs.
21:4.0.1.1.2.4.1.3	SECTION 201.115	201.115 New drugs or new animal drugs.
21:4.0.1.1.2.4.1.4	SECTION 201.116	201.116 Drugs having commonly known directions.
21:4.0.1.1.2.4.1.5	SECTION 201.117	201.117 Inactive ingredients.
21:4.0.1.1.2.4.1.6	SECTION 201.119	201.119 In vitro diagnostic products.
21:4.0.1.1.2.4.1.7	SECTION 201.120	201.120 Prescription chemicals and other prescription components.
21:4.0.1.1.2.4.1.8	SECTION 201.122	201.122 Drugs for processing, repacking, or manufacturing.
21:4.0.1.1.2.4.1.9	SECTION 201.125	201.125 Drugs for use in teaching, law enforcement, research, and analysis.
21:4.0.1.1.2.4.1.10	SECTION 201.127	201.127 Drugs; expiration of exemptions.
21:4.0.1.1.2.4.1.11	SECTION 201.128	201.128 Meaning of “intended uses”.
21:4.0.1.1.2.4.1.13	SECTION 201.129	201.129 Drugs; exemption for radioactive drugs for research use.

---